Stammdaten
Werewolf Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen, das Therapeutika entwickelt, die das Immunsystem des Körpers zur Krebsbehandlung stimulieren. Das Unternehmen entwirft über seine proprietäre PREDATOR-Plattform bedingt aktivierte Moleküle, die adaptive und angeborene Immunität stimulieren, um die Beschränkungen konventioneller pro-inflammatorischer Immuntherapien zu überwinden. Die führenden Produktkandidaten sind WTX-124, ein bedingt aktiviertes Interleukin-2-INDUKINE-Molekül zur Behandlung fortgeschrittener solider Tumoren, und WTX-330, ein bedingt aktiviertes Interleukin-12-INDUKINE-Molekül zur Behandlung rückfälliger oder therapieresistenter fortgeschrittener oder metastasierter solider Tumoren oder Lymphome. Das Unternehmen entwickelt auch WTX-613, ein bedingt aktiviertes Interferon-alpha-INDUKINE-Molekül zur Behandlung solider Tumoren und hämatologischer Malignome. Werewolf Therapeutics, Inc. wurde 2017 gegründet und hat seinen Hauptsitz in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Werewolf Therapeutics, Inc. |
|---|---|
| Ticker | HOWL |
| CIK | 0001785530 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 95075A107 |
|---|---|
| ISIN | US95075A1079 |
| Typ | Common Stock |
| Marktkapitalisierung | 17,1 Mio. USD |
| Beta | 0,37 |
Bewertung
| KBV (P/B) | 0,69 vs. 2,13 (2021) ▼ |
|---|---|
| FCF-Rendite | -353,2 % vs. -13,3 % (2021) ▼ |
Qualität & Bilanz
| ROIC | -91,7 % vs. -29,7 % (2021) ▼ |
|---|---|
| Zinsdeckungsgrad | -11,5 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 2,13 | 0,53 | 1,36 | 0,90 | 1,24 | 1,40 | |
| FCF-Rendite | -13,3 % | -68,6 % | -22,1 % | -85,1 % | -195,8 % | -304,2 % | |
| Qualität & Bilanz | |||||||
| ROIC | -29,7 % | -39,3 % | -22,8 % | -60,5 % | -91,7 % | -105,9 % | |
| Zinsdeckungsgrad | – | – | -12,9 | -15,8 | -11,5 | -10,4 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
HOWL
Werewolf Therapeutics, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 62 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv
Neutral
Handelsvolumen
Sehr niedrig
Insider
0,0
Keine Insider-Käufe
Institutionell
63,3
7 neu, 9 erhöht, 1,7M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 0.60 | -37.9 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 0.93 | -60.2 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 0.42 | EMA50: 0.54 | |
| MACD-Histogramm | Bullisch | 10 % | 0.008 | Bullisch | |
| RSI(14) | Neutral | 10 % | 35.4 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 24.0 | Neutral | |
| ADX(14)+DI | Bärisch | 10 % | 33.8 | +DI: 11.5 / −DI: 24.9 | |
| Z-Score(60) | Neutral | 5 % | -1.25 | In Range | |
| 52W-Position | Bärisch | 5 % | 1.4 % | Hoch 2.19 / Tief 0.34 | |
| Bollinger(20,2σ) | Neutral | 5 % | 27.8 % | Upper 0.49 / Mid 0.41 / Lower 0.32 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.0121 | R²=0.89 / annualisiert -470.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -389.216 | 0,35 | -136.225,60 | -254,2% | |
| 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -27.695 | 0,35 | -9.693,25 | -18,1% | |
| 2026-06-16 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -139.686 | 0,37 | -51.683,82 | -96,4% | |
| 2026-06-16 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -9.939 | 0,37 | -3.677,43 | -6,9% | |
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -8.554 | 0,39 | -3.336,06 | -6,2% | |
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -120.216 | 0,39 | -46.884,24 | -87,5% | |
| 2026-06-12 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -159.119 | 0,40 | -63.647,60 | -118,8% | |
| 2026-06-12 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -11.322 | 0,40 | -4.528,80 | -8,5% | |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -245.066 | 0,38 | -93.125,08 | -173,8% | |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -17.437 | 0,38 | -6.626,06 | -12,4% | |
| 2026-06-10 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -42.872 | 0,37 | -15.862,64 | -29,6% | |
| 2026-06-10 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -3.051 | 0,37 | -1.128,87 | -2,1% | |
| 2026-06-09 | EVNIN LUKE | Director | Open Market Sale | -76.928 | 0,37 | -28.463,36 | -53,1% | |
| 2026-06-09 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -345.235 | 0,37 | -127.736,95 | -238,4% | |
| 2026-06-09 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -24.565 | 0,37 | -9.089,05 | -17,0% | |
| 2026-06-08 | EVNIN LUKE | Director | Open Market Sale | -60.547 | 0,40 | -24.218,80 | -45,2% | |
| 2026-06-05 | EVNIN LUKE | Director | Open Market Sale | -24.946 | 0,40 | -9.978,40 | -18,6% | |
| 2026-06-04 | EVNIN LUKE | Director | Open Market Sale | -20.072 | 0,44 | -8.831,68 | -16,5% | |
| 2026-06-03 | EVNIN LUKE | Director | Open Market Sale | -29.749 | 0,42 | -12.494,58 | -23,3% | |
| 2026-06-02 | EVNIN LUKE | Director | Open Market Sale | -29.595 | 0,45 | -13.317,75 | -24,9% | |
| 2026-06-01 | EVNIN LUKE | Director | Open Market Sale | -80.459 | 0,47 | -37.815,73 | -70,6% | |
| 2026-05-29 | EVNIN LUKE | Director | Open Market Sale | -32.556 | 0,45 | -14.650,20 | -27,3% | |
| 2026-05-28 | EVNIN LUKE | Director | Open Market Sale | -27.698 | 0,46 | -12.741,08 | -23,8% | |
| 2026-05-27 | EVNIN LUKE | Director | Open Market Sale | -80.852 | 0,48 | -38.808,96 | -72,4% | |
| 2026-05-26 | EVNIN LUKE | Director | Open Market Sale | -67.950 | 0,47 | -31.936,50 | -59,6% | |
| 2026-05-22 | EVNIN LUKE | Director | Open Market Sale | -87.425 | 0,45 | -39.341,25 | -73,4% | |
| 2026-05-21 | EVNIN LUKE | Director | Open Market Sale | -36.387 | 0,42 | -15.282,54 | -28,5% | |
| 2026-05-20 | EVNIN LUKE | Director | Open Market Sale | -85.895 | 0,43 | -36.934,85 | -68,9% | |
| 2026-05-19 | EVNIN LUKE | Director | Open Market Sale | -62.970 | 0,45 | -28.336,50 | -52,9% | |
| 2026-05-18 | EVNIN LUKE | Director | Open Market Sale | -22.184 | 0,50 | -11.092,00 | -20,7% | |
| 2026-05-13 | EVNIN LUKE | Director | Open Market Sale | -44.679 | 0,54 | -24.126,66 | -45,0% | |
| 2026-05-12 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -6.719 | 0,64 | -4.300,16 | -8,0% | |
| 2026-05-12 | EVNIN LUKE | Director | Open Market Sale | -67.885 | 0,64 | -43.446,40 | -81,1% | |
| 2026-05-12 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -94.432 | 0,64 | -60.436,48 | -112,8% | |
| 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -81.678 | 0,67 | -54.724,26 | -102,1% | |
| 2026-05-11 | EVNIN LUKE | Director | Open Market Sale | -33.948 | 0,67 | -22.745,16 | -42,4% | |
| 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -5.812 | 0,67 | -3.894,04 | -7,3% | |
| 2026-05-08 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -351.514 | 0,71 | -249.574,94 | -465,7% | |
| 2026-05-08 | EVNIN LUKE | Director | Open Market Sale | -305.741 | 0,70 | -214.018,70 | -399,4% | |
| 2026-05-08 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Open Market Sale | -25.012 | 0,71 | -17.758,52 | -33,1% | |
| 2026-05-07 | EVNIN LUKE | Director | Open Market Sale | -79.086 | 0,63 | -49.824,18 | -93,0% | |
| 2026-05-06 | EVNIN LUKE | Director | Open Market Sale | -14.635 | 0,66 | -9.659,10 | -18,0% | |
| 2026-05-05 | EVNIN LUKE | Director | Open Market Sale | -6.860 | 0,69 | -4.733,40 | -8,8% | |
| 2026-05-04 | EVNIN LUKE | Director | Open Market Sale | -47.963 | 0,72 | -34.533,36 | -64,4% | |
| 2026-05-01 | EVNIN LUKE | Director | Open Market Sale | -58.394 | 0,73 | -42.627,62 | -79,5% | |
| 2026-04-30 | EVNIN LUKE | Director | Open Market Sale | -168.262 | 0,72 | -121.148,64 | -226,1% | |
| 2026-04-29 | EVNIN LUKE | Director | Open Market Sale | -56.559 | 0,69 | -39.025,71 | -72,8% | |
| 2026-04-28 | EVNIN LUKE | Director | Open Market Sale | -95.412 | 0,73 | -69.650,76 | -130,0% | |
| 2026-04-27 | EVNIN LUKE | Director | Open Market Sale | -53.940 | 0,85 | -45.849,00 | -85,6% | |
| 2026-01-16 | EVNIN LUKE | Director | Open Market Sale | -38.782 | 0,54 | -20.942,28 | -39,1% | |
| 2026-01-15 | EVNIN LUKE | Director | Open Market Sale | -37.413 | 0,55 | -20.577,15 | -38,4% | |
| 2026-01-14 | EVNIN LUKE | Director | Open Market Sale | -30.616 | 0,57 | -17.451,12 | -32,6% | |
| 2026-01-13 | EVNIN LUKE | Director | Open Market Sale | -43.198 | 0,55 | -23.758,90 | -44,3% | |
| 2026-01-12 | EVNIN LUKE | Director | Open Market Sale | -58.980 | 0,57 | -33.618,60 | -62,7% | |
| 2026-01-09 | EVNIN LUKE | Director | Open Market Sale | -24.678 | 0,61 | -15.053,58 | -28,1% | |
| 2026-01-08 | EVNIN LUKE | Director | Open Market Sale | -7.716 | 0,63 | -4.861,08 | -9,1% | |
| 2026-01-07 | EVNIN LUKE | Director | Open Market Sale | -11.915 | 0,64 | -7.625,60 | -14,2% | |
| 2026-01-06 | EVNIN LUKE | Director | Open Market Sale | -40.761 | 0,65 | -26.494,65 | -49,4% | |
| 2026-01-05 | EVNIN LUKE | Director | Open Market Sale | -18.378 | 0,64 | -11.761,92 | -21,9% | |
| 2026-01-02 | EVNIN LUKE | Director | Open Market Sale | -18.568 | 0,63 | -11.697,84 | -21,8% | |
| 2025-12-31 | EVNIN LUKE | Director | Open Market Sale | -24.962 | 0,62 | -15.476,44 | -28,9% | |
| 2025-12-30 | EVNIN LUKE | Director | Open Market Sale | -34.847 | 0,61 | -21.256,67 | -39,7% | |
| 2025-12-29 | EVNIN LUKE | Director | Open Market Sale | -108.606 | 0,61 | -66.249,66 | -123,6% | |
| 2025-12-26 | EVNIN LUKE | Director | Open Market Sale | -35.632 | 0,63 | -22.448,16 | -41,9% | |
| 2025-12-24 | EVNIN LUKE | Director | Open Market Sale | -16.310 | 0,65 | -10.601,50 | -19,8% | |
| 2025-12-23 | EVNIN LUKE | Director | Open Market Sale | -71.428 | 0,63 | -44.999,64 | -84,0% | |
| 2025-12-22 | EVNIN LUKE | Director | Open Market Sale | -59.307 | 0,69 | -40.921,83 | -76,4% | |
| 2025-12-17 | EVNIN LUKE | Director | Open Market Sale | -9.983 | 1,14 | -11.380,62 | -21,2% | |
| 2025-12-16 | EVNIN LUKE | Director | Open Market Sale | -14.548 | 1,05 | -15.275,40 | -28,5% | |
| 2025-12-15 | EVNIN LUKE | Director | Open Market Sale | -23.640 | 1,07 | -25.294,80 | -47,2% | |
| 2025-12-12 | EVNIN LUKE | Director | Open Market Sale | -17.858 | 1,08 | -19.286,64 | -36,0% | |
| 2025-12-11 | EVNIN LUKE | Director | Open Market Sale | -28.009 | 1,07 | -29.969,63 | -55,9% | |
| 2025-12-10 | EVNIN LUKE | Director | Open Market Sale | -37.104 | 1,06 | -39.330,24 | -73,4% | |
| 2025-12-09 | EVNIN LUKE | Director | Open Market Sale | -44.570 | 1,01 | -45.015,70 | -84,0% | |
| 2025-12-08 | EVNIN LUKE | Director | Open Market Sale | -34.041 | 0,99 | -33.700,59 | -62,9% | |
| 2025-12-05 | EVNIN LUKE | Director | Open Market Sale | -16.568 | 0,97 | -16.070,96 | -30,0% | |
| 2025-12-04 | EVNIN LUKE | Director | Open Market Sale | -53.416 | 0,97 | -51.813,52 | -96,7% | |
| 2025-12-04 | MPM BioVentures 2014, L.P. | Open Market Sale | -83.230 | 0,97 | -80.733,10 | -150,7% | ||
| 2025-12-04 | GADICKE ANSBERT | Open Market Sale | -83.230 | 0,97 | -80.733,10 | -150,7% | ||
| 2025-12-03 | GADICKE ANSBERT | Open Market Sale | -57.225 | 0,87 | -49.785,75 | -92,9% | ||
| 2025-12-03 | EVNIN LUKE | Director | Open Market Sale | -36.726 | 0,87 | -31.951,62 | -59,6% | |
| 2025-12-03 | MPM BioVentures 2014, L.P. | Open Market Sale | -57.225 | 0,87 | -49.785,75 | -92,9% | ||
| 2025-12-02 | MPM BioVentures 2014, L.P. | Open Market Sale | -59.277 | 0,89 | -52.756,53 | -98,4% | ||
| 2025-12-02 | EVNIN LUKE | Director | Open Market Sale | -38.043 | 0,89 | -33.858,27 | -63,2% | |
| 2025-12-02 | GADICKE ANSBERT | Open Market Sale | -59.277 | 0,89 | -52.756,53 | -98,4% | ||
| 2025-12-01 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -60.917 | 0,94 | -57.261,98 | -106,9% | |
| 2025-12-01 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -60.917 | 0,94 | -57.261,98 | -106,9% | |
| 2025-12-01 | EVNIN LUKE | Director | Open Market Sale | -39.096 | 0,94 | -36.750,24 | -68,6% | |
| 2025-11-28 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -20.277 | 0,99 | -20.074,23 | -37,5% | |
| 2025-11-28 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -20.277 | 0,99 | -20.074,23 | -37,5% | |
| 2025-11-28 | EVNIN LUKE | Director | Open Market Sale | -13.014 | 0,99 | -12.883,86 | -24,0% | |
| 2025-11-26 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -60.733 | 0,98 | -59.518,34 | -111,1% | |
| 2025-11-26 | EVNIN LUKE | Director | Open Market Sale | -38.978 | 0,98 | -38.198,44 | -71,3% | |
| 2025-11-26 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -60.733 | 0,98 | -59.518,34 | -111,1% | |
| 2025-11-25 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -42.533 | 0,92 | -39.130,36 | -73,0% | |
| 2025-11-25 | EVNIN LUKE | Director | Open Market Sale | -27.297 | 0,92 | -25.113,24 | -46,9% | |
| 2025-11-25 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -42.533 | 0,92 | -39.130,36 | -73,0% | |
| 2025-11-24 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -88.802 | 0,98 | -87.025,96 | -162,4% | |
| 2025-11-24 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -88.802 | 0,98 | -87.025,96 | -162,4% | |
| 2025-11-24 | EVNIN LUKE | Director | Open Market Sale | -56.992 | 0,98 | -55.852,16 | -104,2% | |
| 2025-11-21 | EVNIN LUKE | Director | Open Market Sale | -41.287 | 0,83 | -34.268,21 | -63,9% | |
| 2025-11-21 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -64.331 | 0,83 | -53.394,73 | -99,6% | |
| 2025-11-21 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -64.331 | 0,83 | -53.394,73 | -99,6% | |
| 2025-11-20 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -41.152 | 0,89 | -36.625,28 | -68,3% | |
| 2025-11-20 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -41.152 | 0,89 | -36.625,28 | -68,3% | |
| 2025-11-20 | EVNIN LUKE | Director | Open Market Sale | -26.411 | 0,89 | -23.505,79 | -43,9% | |
| 2025-11-19 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -66.324 | 0,94 | -62.344,56 | -116,3% | |
| 2025-11-19 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -66.324 | 0,94 | -62.344,56 | -116,3% | |
| 2025-11-19 | EVNIN LUKE | Director | Open Market Sale | -42.566 | 0,94 | -40.012,04 | -74,7% | |
| 2025-11-18 | EVNIN LUKE | Director | Open Market Sale | -33.776 | 0,93 | -31.411,68 | -58,6% | |
| 2025-11-18 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -52.627 | 0,93 | -48.943,11 | -91,3% | |
| 2025-11-18 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -52.627 | 0,93 | -48.943,11 | -91,3% | |
| 2025-11-17 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -57.061 | 0,95 | -54.207,95 | -101,2% | |
| 2025-11-17 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -57.061 | 0,95 | -54.207,95 | -101,2% | |
| 2025-11-17 | EVNIN LUKE | Director | Open Market Sale | -36.621 | 0,95 | -34.789,95 | -64,9% | |
| 2025-11-14 | EVNIN LUKE | Director | Open Market Sale | -39.560 | 0,93 | -36.790,80 | -68,7% | |
| 2025-11-14 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -61.640 | 0,93 | -57.325,20 | -107,0% | |
| 2025-11-14 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -61.640 | 0,93 | -57.325,20 | -107,0% | |
| 2025-11-13 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -90.951 | 0,98 | -89.131,98 | -166,3% | |
| 2025-11-13 | EVNIN LUKE | Director | Open Market Sale | -58.372 | 0,98 | -57.204,56 | -106,7% | |
| 2025-11-13 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -90.951 | 0,98 | -89.131,98 | -166,3% | |
| 2025-11-12 | EVNIN LUKE | Director | Open Market Sale | -26.101 | 1,09 | -28.450,09 | -53,1% | |
| 2025-11-12 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -40.669 | 1,09 | -44.329,21 | -82,7% | |
| 2025-11-12 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -40.669 | 1,09 | -44.329,21 | -82,7% | |
| 2025-11-11 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -55.810 | 1,14 | -63.623,40 | -118,7% | |
| 2025-11-11 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -55.810 | 1,14 | -63.623,40 | -118,7% | |
| 2025-11-11 | EVNIN LUKE | Director | Open Market Sale | -35.818 | 1,14 | -40.832,52 | -76,2% | |
| 2025-11-10 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -48.570 | 1,18 | -57.312,60 | -106,9% | |
| 2025-11-10 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -48.570 | 1,18 | -57.312,60 | -106,9% | |
| 2025-11-10 | EVNIN LUKE | Director | Open Market Sale | -31.172 | 1,18 | -36.782,96 | -68,6% | |
| 2025-11-07 | EVNIN LUKE | Director | Open Market Sale | -43.950 | 1,11 | -48.784,50 | -91,0% | |
| 2025-11-07 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -68.480 | 1,11 | -76.012,80 | -141,8% | |
| 2025-11-07 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -68.480 | 1,11 | -76.012,80 | -141,8% | |
| 2025-11-06 | EVNIN LUKE | Director | Open Market Sale | -34.947 | 1,21 | -42.285,87 | -78,9% | |
| 2025-11-06 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -54.452 | 1,21 | -65.886,92 | -122,9% | |
| 2025-11-06 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -54.452 | 1,21 | -65.886,92 | -122,9% | |
| 2025-11-05 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -47.950 | 1,22 | -58.499,00 | -109,2% | |
| 2025-11-05 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -47.950 | 1,22 | -58.499,00 | -109,2% | |
| 2025-11-05 | EVNIN LUKE | Director | Open Market Sale | -30.774 | 1,22 | -37.544,28 | -70,1% | |
| 2025-11-04 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -140.488 | 1,22 | -171.395,36 | -319,8% | |
| 2025-11-04 | EVNIN LUKE | Director | Open Market Sale | -90.164 | 1,22 | -110.000,08 | -205,3% | |
| 2025-11-04 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -140.488 | 1,22 | -171.395,36 | -319,8% | |
| 2025-11-03 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -94.063 | 1,29 | -121.341,27 | -226,4% | |
| 2025-11-03 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -94.063 | 1,29 | -121.341,27 | -226,4% | |
| 2025-11-03 | EVNIN LUKE | Director | Open Market Sale | -60.369 | 1,29 | -77.876,01 | -145,3% | |
| 2025-10-31 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -114.044 | 1,28 | -145.976,32 | -272,4% | |
| 2025-10-31 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -114.044 | 1,28 | -145.976,32 | -272,4% | |
| 2025-10-31 | EVNIN LUKE | Director | Open Market Sale | -73.192 | 1,28 | -93.685,76 | -174,8% | |
| 2025-10-30 | EVNIN LUKE | Director | Open Market Sale | -55.795 | 1,43 | -79.786,85 | -148,9% | |
| 2025-10-30 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -86.936 | 1,43 | -124.318,48 | -232,0% | |
| 2025-10-30 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -86.936 | 1,43 | -124.318,48 | -232,0% | |
| 2025-10-29 | EVNIN LUKE | Director | Open Market Sale | -86.154 | 1,55 | -133.538,70 | -249,2% | |
| 2025-10-29 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -134.240 | 1,55 | -208.072,00 | -388,3% | |
| 2025-10-29 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -134.240 | 1,55 | -208.072,00 | -388,3% | |
| 2025-10-28 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -69.068 | 1,64 | -113.271,52 | -211,4% | |
| 2025-10-28 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -69.068 | 1,64 | -113.271,52 | -211,4% | |
| 2025-10-28 | EVNIN LUKE | Director | Open Market Sale | -44.327 | 1,64 | -72.696,28 | -135,7% | |
| 2025-10-27 | EVNIN LUKE | Director | Open Market Sale | -46.664 | 1,72 | -80.262,08 | -149,8% | |
| 2025-10-27 | GADICKE ANSBERT | 10% Owner | Open Market Sale | -72.709 | 1,72 | -125.059,48 | -233,4% | |
| 2025-10-27 | MPM BioVentures 2014, L.P. | 10% Owner | Open Market Sale | -72.709 | 1,72 | -125.059,48 | -233,4% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6.681.307 | 6.681.307 | 0 | 5.562.856 | Unverändert | 0,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.217.976 | 0 | 1.217.976 | 1.014.574 | Neu | +100,0% | |
| MPM BioImpact LLC | 1.208.810 | 1.393.557 | -184.747 | 1.006.455 | Reduziert | -13,3% | |
| VANGUARD GROUP INC | 1.408.047 | 0 | 1.408.047 | 892.702 | Neu | +100,0% | |
| Lynx1 Capital Management LP | 657.786 | 655.926 | 1.860 | 547.673 | Aufgestockt | +0,3% | |
| SPHERA FUNDS MANAGEMENT LTD. | 626.810 | 626.810 | 0 | 521.882 | Unverändert | 0,0% | |
| DC Funds, LP | 589.102 | 589.102 | 0 | 490.486 | Unverändert | 0,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 516.218 | 677.766 | -161.548 | 429.803 | Reduziert | -23,8% | |
| GEODE CAPITAL MANAGEMENT, LLC | 389.487 | 335.886 | 53.601 | 324.363 | Aufgestockt | +16,0% | |
| BANK OF AMERICA CORP /DE/ | 264.583 | 737.550 | -472.967 | 220.133 | Reduziert | -64,1% | |
| MILLENNIUM MANAGEMENT LLC | 132.050 | 240.109 | -108.059 | 109.945 | Reduziert | -45,0% | |
| STATE STREET CORP | 119.168 | 119.168 | 0 | 99.219 | Unverändert | 0,0% | |
| BlackRock, Inc. | 101.608 | 101.643 | -35 | 84.598 | Reduziert | 0,0% | |
| NORTHERN TRUST CORP | 86.851 | 86.851 | 0 | 72.312 | Unverändert | 0,0% | |
| Alyeska Investment Group, L.P. | 86.554 | 235.705 | -149.151 | 72.065 | Reduziert | -63,3% | |
| JANE STREET GROUP, LLC | 82.836 | 157.322 | -74.486 | 68.969 | Reduziert | -47,3% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77.000 | 77.000 | 0 | 64.110 | Unverändert | 0,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 99.829 | 0 | 99.829 | 63.242 | Neu | +100,0% | |
| UBS Group AG | 66.857 | 60.708 | 6.149 | 55.692 | Aufgestockt | +10,1% | |
| XTX Topco Ltd | 50.929 | 0 | 50.929 | 42.403 | Neu | +100,0% | |
| Vontobel Holding Ltd. | 60.003 | 0 | 60.003 | 38.012 | Neu | +100,0% | |
| Regal Investment Advisors LLC | 52.593 | 0 | 52.593 | 33.318 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 38.266 | 34.073 | 4.193 | 31.860 | Aufgestockt | +12,3% | |
| EDGEWOOD MANAGEMENT LLC | 50.000 | 0 | 50.000 | 31.675 | Neu | +100,0% | |
| MORGAN STANLEY | 33.799 | 46.002 | -12.203 | 28.141 | Reduziert | -26,5% | |
| SIMPLEX TRADING, LLC | 32.526 | 24.054 | 8.472 | 27.094 | Aufgestockt | +35,2% | |
| Verdad Advisers, LP | 29.760 | 0 | 29.760 | 24.778 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 19.778 | 0 | 19.778 | 16.467 | Neu | +100,0% | |
| CERTUITY, LLC | 15.000 | 15.000 | 0 | 12.489 | Unverändert | 0,0% | |
| Delta Investment Management, LLC | 14.925 | 14.925 | 0 | 12.427 | Unverändert | 0,0% | |
| BARCLAYS PLC | 13.235 | 13.236 | -1 | 11.020 | Reduziert | 0,0% | |
| Larson Financial Group LLC | 13.052 | 13.052 | 0 | 10.867 | Unverändert | 0,0% | |
| Ranch Capital Advisors Inc. | 12.000 | 12.000 | 0 | 9.991 | Unverändert | 0,0% | |
| Point72 Asset Management, L.P. | 14.483 | 0 | 14.483 | 9.175 | Neu | +100,0% | |
| HBK Sorce Advisory LLC | 13.227 | 13.227 | 0 | 8.994 | Unverändert | 0,0% | |
| CITADEL ADVISORS LLC | 10.382 | 0 | 10.382 | 8.644 | Neu | +100,0% | |
| Cetera Investment Advisers | 10.200 | 10.200 | 0 | 8.493 | Unverändert | 0,0% | |
| LPL Financial LLC | 10.000 | 0 | 10.000 | 8.326 | Neu | +100,0% | |
| Engineers Gate Manager LP | 12.185 | 0 | 12.185 | 7.719 | Neu | +100,0% | |
| HIGHLINE WEALTH PARTNERS LLC | 12.000 | 0 | 12.000 | 7.602 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 8.625 | 8.625 | 0 | 7.159 | Unverändert | 0,0% | |
| StoneX Group Inc. | 10.511 | 0 | 10.511 | 6.659 | Neu | +100,0% | |
| TWO SIGMA ADVISERS, LP | 10.300 | 0 | 10.300 | 6.525 | Neu | +100,0% | |
| Financial Perspectives, Inc | 6.750 | 6.750 | 0 | 5.620 | Unverändert | 0,0% | |
| TFC Financial Management, Inc. | 4.500 | 4.500 | 0 | 3.747 | Unverändert | 0,0% | |
| CITIGROUP INC | 3.384 | 1 | 3.383 | 2.818 | Aufgestockt | +338300,0% | |
| FEDERATED HERMES, INC. | 4.387 | 0 | 4.387 | 2.779 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 1.871 | 1.871 | 0 | 1.558 | Unverändert | 0,0% | |
| JPMORGAN CHASE & CO | 2.072 | 0 | 2.072 | 1.313 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 790 | 792 | -2 | 658 | Reduziert | -0,3% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Verlauf |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6.681.307 | 6.681.307 | 0,0% | 5.562.856 | 55,54 | 15 Q |
| MPM BioImpact LLC | 1.208.810 | 1.393.557 | -13,3% | 1.006.455 | 10,05 | 17 Q |
| Lynx1 Capital Management LP | 657.786 | 655.926 | +0,3% | 547.673 | 5,47 | 2 Q |
| SPHERA FUNDS MANAGEMENT LTD. | 626.810 | 626.810 | 0,0% | 521.882 | 5,21 | 16 Q |
| DC Funds, LP | 589.102 | 589.102 | 0,0% | 490.486 | 4,90 | 17 Q |
| RENAISSANCE TECHNOLOGIES LLC | 516.218 | 677.766 | -23,8% | 429.803 | 4,29 | 16 Q |
| GEODE CAPITAL MANAGEMENT, LLC | 389.487 | 335.886 | +16,0% | 324.363 | 3,24 | 17 Q |
| BANK OF AMERICA CORP /DE/ | 264.583 | 737.550 | -64,1% | 220.133 | 2,20 | 14 Q |
| MILLENNIUM MANAGEMENT LLC | 132.050 | 240.109 | -45,0% | 109.945 | 1,10 | 17 Q |
| STATE STREET CORP | 119.168 | 119.168 | 0,0% | 99.219 | 0,99 | 17 Q |
| BlackRock, Inc. | 101.608 | 101.643 | 0,0% | 84.598 | 0,84 | 7 Q |
| NORTHERN TRUST CORP | 86.851 | 86.851 | 0,0% | 72.312 | 0,72 | 17 Q |
| Alyeska Investment Group, L.P. | 86.554 | 235.705 | -63,3% | 72.065 | 0,72 | 17 Q |
| JANE STREET GROUP, LLC | 82.836 | 157.322 | -47,3% | 68.969 | 0,69 | 10 Q |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77.000 | 77.000 | 0,0% | 64.110 | 0,64 | 16 Q |
| UBS Group AG | 66.857 | 60.708 | +10,1% | 55.692 | 0,56 | 17 Q |
| XTX Topco Ltd | 50.929 | 0 | +100,0% | 42.403 | 0,42 | 3 Q |
| GOLDMAN SACHS GROUP INC | 38.266 | 34.073 | +12,3% | 31.860 | 0,32 | 11 Q |
| MORGAN STANLEY | 33.799 | 46.002 | -26,5% | 28.141 | 0,28 | 17 Q |
| SIMPLEX TRADING, LLC | 32.526 | 24.054 | +35,2% | 27.094 | 0,27 | 14 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 47 | 14,7 | 12 |
| 31.12.2025 | ✓ | 51 | 14,8 | 9 |
| 30.09.2025 | ✓ | 62 | 23,0 | 45 |
| 30.06.2025 | ✓ | 66 | 22,4 | 24 |
| 31.03.2025 | ✓ | 71 | 27,9 | 27 |
| 31.12.2024 | ✓ | 75 | 28,5 | 42 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Lynx1 Capital Management LP | 655.926 | 415.529 |
| Delta Investment Management, LLC | 14.925 | 9.455 |
| Point72 Asset Management, L.P. | 14.483 | 9.175 |
| Engineers Gate Manager LP | 12.185 | 7.719 |
| Ranch Capital Advisors Inc. | 12.000 | 7.602 |
| StoneX Group Inc. | 10.511 | 6.659 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 4 | 3 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 677.766 | 221.766 | +48.6 % | 429.365 |
| UBS Group AG | 60.708 | 47.932 | +375.2 % | 38.428 |
| MORGAN STANLEY | 46.002 | 26.750 | +138.9 % | 29.142 |
| Regal Investment Advisors LLC | 52.593 | 25.389 | +93.3 % | 33.318 |
| Vontobel Holding Ltd. | 60.003 | 24.003 | +66.7 % | 38.012 |
| NORTHERN TRUST CORP | 86.851 | 21.015 | +31.9 % | 55.020 |
| SIMPLEX TRADING, LLC | 24.054 | 8.418 | +53.8 % | 15.250 |
| HIGHLINE WEALTH PARTNERS LLC | 12.000 | 7.000 | +140.0 % | 7.602 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 99.829 | 6.788 | +7.3 % | 63.242 |
| GEODE CAPITAL MANAGEMENT, LLC | 335.886 | 5.099 | +1.5 % | 212.838 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 737.550 | -1.092.742 | -59.7 % | 466.869 |
| MPM BioImpact LLC | 1.393.557 | -1.015.253 | -42.1 % | 883.515 |
| JANE STREET GROUP, LLC | 157.322 | -111.255 | -41.4 % | 99.663 |
| MILLENNIUM MANAGEMENT LLC | 240.109 | -76.944 | -24.3 % | 152.109 |
| GOLDMAN SACHS GROUP INC | 34.073 | -26.268 | -43.5 % | 21.585 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77.000 | -25.000 | -24.5 % | 48.780 |
| TWO SIGMA ADVISERS, LP | 10.300 | -24.300 | -70.2 % | 6.525 |
| CITIGROUP INC | 1 | -8.660 | -100.0 % | 1 |
| FMR LLC | 3.631 | -7.653 | -67.8 % | 2.300 |
| GROUP ONE TRADING LLC | 1.871 | -1.800 | -49.0 % | 1.185 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck | Δ visuell |
|---|---|---|---|---|---|---|---|
| 23.06.2026 | RA Capital Management, L.P. (+2) | Aktivist (13D/A) | 7,50 % | 3.654.307 | -3,10 pp | ||
| 23.06.2026 | RA Capital Healthcare Fund, L.P. | Aktivist (13D/A) | 7,00 % | 3.411.559 | -2,90 pp | ||
| 16.06.2026 | RA Capital Management, L.P. (+2) | Aktivist (13D/A) | 10,60 % | 5.138.703 | -2,00 pp | ||
| 16.06.2026 | RA Capital Healthcare Fund, L.P. | Aktivist (13D/A) | 9,90 % | 4.797.350 | -1,80 pp | ||
| 14.05.2026 | RA Capital Management, L.P. (+2) | Aktivist (13D/A) | 12,60 % | 6.116.140 | -1,20 pp | ||
| 14.05.2026 | RA Capital Healthcare Fund, L.P. | Aktivist (13D/A) | 11,70 % | 5.709.858 | -1,20 pp | ||
| 13.05.2026 | MPM BioVentures 2014 GP LLC | Aktivist (13D/A) | 1,70 % | 845.094 | -0,80 pp | ||
| 13.05.2026 | MPM Asset Management Investors BV2014 LLC | Aktivist (13D/A) | 0,10 % | 27.267 | 0,00 pp | ||
| 13.05.2026 | MPM BioVentures 2014 (B), L.P. | Aktivist (13D/A) | 0,10 % | 52.840 | -0,10 pp | ||
| 13.05.2026 | MPM BioVentures 2014 LLC (+1) | Aktivist (13D/A) | 1,80 % | 872.361 | -0,80 pp | ||
| 13.05.2026 | LUKE EVNIN | Aktivist (13D/A) | 2,40 % | 1.171.175 | -1,00 pp | ||
| 13.05.2026 | MPM ASSET MANAGEMENT LLC | Aktivist (13D/A) | 0,30 % | 125.480 | -0,10 pp | ||
| 13.05.2026 | MPM BioVentures 2014, L.P. | Aktivist (13D/A) | 1,60 % | 792.254 | -0,70 pp | ||
| 13.05.2026 | MPM Oncology Innovations Fund GP LLC (+1) | Aktivist (13D/A) | 0,40 % | 173.334 | -0,10 pp | ||
| 13.05.2026 | Oncology Impact Fund (Cayman) Management L.P. (+2) | Aktivist (13D/A) | 1,30 % | 655.471 | -0,60 pp | ||
| 13.05.2026 | ANSBERT GADICKE | Aktivist (13D/A) | 3,80 % | 1.826.646 | -1,60 pp | ||
| 05.05.2026 | MPM Asset Management Investors BV2014 LLC | Aktivist (13D/A) | 0,10 % | 38.939 | 0,00 pp | ||
| 05.05.2026 | MPM BioVentures 2014, L.P. | Aktivist (13D/A) | 2,30 % | 1.131.359 | -0,70 pp | ||
| 05.05.2026 | MPM BioVentures 2014 LLC (+1) | Aktivist (13D/A) | 2,60 % | 1.245.756 | -0,70 pp | ||
| 05.05.2026 | MPM BioVentures 2014 (B), L.P. | Aktivist (13D/A) | 0,20 % | 75.458 | 0,00 pp | ||
| 05.05.2026 | LUKE EVNIN | Aktivist (13D/A) | 3,40 % | 1.672.470 | -1,00 pp | ||
| 05.05.2026 | MPM BioVentures 2014 GP LLC | Aktivist (13D/A) | 2,50 % | 1.206.817 | -0,70 pp | ||
| 05.05.2026 | Oncology Impact Fund (Cayman) Management L.P. (+2) | Aktivist (13D/A) | 1,90 % | 936.031 | -0,60 pp | ||
| 05.05.2026 | MPM ASSET MANAGEMENT LLC | Aktivist (13D/A) | 0,40 % | 179.188 | -0,10 pp | ||
| 05.05.2026 | ANSBERT GADICKE | Aktivist (13D/A) | 5,40 % | 2.608.501 | -1,50 pp | ||
| 05.05.2026 | MPM Oncology Innovations Fund GP LLC (+1) | Aktivist (13D/A) | 0,50 % | 247.526 | -0,20 pp | ||
| 11.02.2026 | Longwood Fund III GP, LLC (+1) | Passiv (13G/A) | 3,50 % | 1.677.082 | -2,60 pp | ||
| 16.01.2026 | MPM BioVentures 2014, L.P. | Aktivist (13D/A) | 3,00 % | 1.461.054 | -0,60 pp | ||
| 16.01.2026 | ANSBERT GADICKE | Aktivist (13D/A) | 6,90 % | 3.368.670 | -1,30 pp | ||
| 16.01.2026 | MPM Asset Management Investors BV2014 LLC | Aktivist (13D/A) | 0,10 % | 50.289 | 0,00 pp | ||
| 16.01.2026 | Oncology Impact Fund (Cayman) Management L.P. (+2) | Aktivist (13D/A) | 2,50 % | 1.208.810 | -0,40 pp | ||
| 16.01.2026 | MPM BioVentures 2014 LLC (+1) | Aktivist (13D/A) | 3,30 % | 1.608.793 | -0,60 pp | ||
| 16.01.2026 | MPM Oncology Innovations Fund GP LLC (+1) | Aktivist (13D/A) | 0,70 % | 319.659 | -0,10 pp | ||
| 16.01.2026 | MPM BioVentures 2014 GP LLC | Aktivist (13D/A) | 3,20 % | 1.558.504 | -0,60 pp | ||
| 16.01.2026 | MPM BioVentures 2014 (B), L.P. | Aktivist (13D/A) | 0,20 % | 97.450 | 0,00 pp | ||
| 16.01.2026 | LUKE EVNIN | Aktivist (13D/A) | 4,40 % | 2.159.860 | -0,90 pp | ||
| 16.01.2026 | MPM ASSET MANAGEMENT LLC | Aktivist (13D/A) | 0,50 % | 231.408 | -0,10 pp | ||
| 29.12.2025 | MPM ASSET MANAGEMENT LLC | Aktivist (13D/A) | 0,60 % | 273.218 | -0,10 pp | ||
| 29.12.2025 | MPM BioVentures 2014, L.P. | Aktivist (13D/A) | 3,60 % | 1.725.184 | -0,70 pp | ||
| 29.12.2025 | Oncology Impact Fund (Cayman) Management L.P. (+2) | Aktivist (13D/A) | 2,90 % | 1.426.938 | -0,70 pp |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | -13.532.000 $ | -0,28 $ | 58.022.000 $ | 12.202.000 $ |
| 2025-12-31 | 10-K | – | -60.822.000 $ | -1,33 $ | 69.396.000 $ | 24.805.000 $ |
| 2025-09-30 | 10-Q | – | -16.370.000 $ | -0,36 $ | 79.627.000 $ | 29.614.000 $ |
| 2025-06-30 | 10-Q | – | -17.982.000 $ | -0,40 $ | 92.566.000 $ | 41.464.000 $ |
| 2025-03-31 | 10-Q | – | -18.089.000 $ | -0,40 $ | 107.236.000 $ | 57.307.000 $ |
| 2024-12-31 | 10-K | – | -70.515.000 $ | -1,63 $ | 126.929.000 $ | 73.390.000 $ |
| 2024-09-30 | 10-Q | – | -16.673.000 $ | -0,38 $ | 140.036.000 $ | 89.379.000 $ |
| 2024-06-30 | 10-Q | – | -17.249.000 $ | -0,43 $ | 153.703.000 $ | 104.018.000 $ |
| 2024-03-31 | 10-Q | – | -16.193.000 $ | -0,39 $ | 177.600.000 $ | 117.587.000 $ |
| 2023-12-31 | 10-K | – | -37.368.000 $ | -1,05 $ | 174.833.000 $ | 111.374.000 $ |
| 2023-09-30 | 10-Q | – | -8.285.000 $ | -0,23 $ | 176.386.000 $ | 112.443.000 $ |
| 2023-06-30 | 10-Q | – | -5.098.000 $ | -0,14 $ | 185.235.000 $ | 118.599.000 $ |
| 2023-03-31 | 10-Q | – | -11.982.000 $ | -0,34 $ | 195.069.000 $ | 121.073.000 $ |
| 2022-12-31 | 10-K | – | -53.810.000 $ | -1,86 $ | 160.245.000 $ | 122.337.000 $ |
| 2022-09-30 | 10-Q | – | -11.943.000 $ | -0,40 $ | 172.424.000 $ | 130.947.000 $ |
| 2022-06-30 | 10-Q | – | -14.594.000 $ | -0,53 $ | 175.329.000 $ | 129.841.000 $ |
| 2022-03-31 | 10-Q | – | -15.343.000 $ | -0,56 $ | 164.631.000 $ | 139.318.000 $ |
| 2021-12-31 | 10-K | – | -49.983.000 $ | -10,94 $ | 179.250.000 $ | 152.787.000 $ |
| 2021-09-30 | 10-Q | – | -13.758.000 $ | -0,51 $ | 178.375.000 $ | 169.303.000 $ |
| 2021-06-30 | 10-Q | – | -10.921.000 $ | -3,82 $ | 190.418.000 $ | 181.556.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | -0,28 |
| Q3 2025 | 30.09.2025 | 04.11.2025 | – | -0,36 |
| Q2 2025 | 30.06.2025 | 04.11.2025 | – | -0,40 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | – | -0,40 |
| Q3 2024 | 30.09.2024 | 04.11.2025 | – | -0,38 |
| Q2 2024 | 30.06.2024 | 04.11.2025 | – | -0,43 |
| Q1 2024 | 31.03.2024 | 04.11.2025 | – | -0,39 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | – | -0,23 |
| Q2 2023 | 30.06.2023 | 07.11.2024 | – | -0,14 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | 31.03.2026 | 37 Tage | SEC » |
| 27.03.2026 | 10-K | 31.12.2025 | 86 Tage | SEC » |
| 04.11.2025 | 10-Q | 30.09.2025 | 35 Tage | SEC » |
| 14.08.2025 | 10-Q | 30.06.2025 | 45 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 11.03.2025 | 10-K | 31.12.2024 | 70 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 03.05.2024 | 10-Q | 31.03.2024 | 33 Tage | SEC » |
| 07.03.2024 | 10-K | 31.12.2023 | 67 Tage | SEC » |
| 14.11.2023 | 10-Q | 30.09.2023 | 45 Tage | SEC » |
| 10.08.2023 | 10-Q | 30.06.2023 | 41 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 23.03.2023 | 10-K | 31.12.2022 | 82 Tage | SEC » |
| 10.11.2022 | 10-Q | 30.09.2022 | 41 Tage | SEC » |
| 11.08.2022 | 10-Q | 30.06.2022 | 42 Tage | SEC » |
| 10.05.2022 | 10-Q | 31.03.2022 | 40 Tage | SEC » |
| 24.03.2022 | 10-K | 31.12.2021 | 83 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 12.08.2021 | 10-Q | 30.06.2021 | 43 Tage | SEC » |
| 10.06.2021 | 10-Q | 31.03.2021 | 71 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 07.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-19 | 580 | 0,50 | 290 |
| 2026-05-08 | 70 | 0,62 | 43 |
| 2026-04-30 | 46.729 | 0,68 | 31.776 |
| 2026-04-21 | 205 | 0,97 | 199 |
| 2026-04-14 | 87 | 0,92 | 80 |
| 2026-04-07 | 3.603 | 1,04 | 3.747 |
| 2026-04-06 | 1.806 | 1,01 | 1.824 |
| 2026-04-02 | 5.183 | 0,96 | 4.976 |
| 2026-03-27 | 2.152 | 0,86 | 1.851 |
| 2026-03-25 | 45 | 0,77 | 35 |
| 2026-03-20 | 449 | 0,81 | 364 |
| 2026-02-26 | 26.326 | 0,64 | 16.849 |
| 2026-02-23 | 1 | 0,67 | 1 |
| 2026-02-05 | 7.792 | 0,64 | 4.987 |
| 2026-02-04 | 20 | 0,66 | 13 |
| 2026-02-02 | 9.454 | 0,66 | 6.240 |
| 2026-01-29 | 340 | 0,71 | 241 |
| 2026-01-21 | 12.259 | 0,56 | 6.865 |
| 2026-01-20 | 17.482 | 0,55 | 9.615 |
| 2026-01-16 | 52.736 | 0,55 | 29.005 |
| 2026-01-15 | 40 | 0,58 | 23 |
| 2026-01-14 | 34.474 | 0,57 | 19.650 |
| 2026-01-08 | 4.098 | 0,64 | 2.623 |
| 2026-01-07 | 8.589 | 0,64 | 5.497 |
| 2026-01-06 | 1.950 | 0,64 | 1.248 |
| 2026-01-05 | 5.706 | 0,64 | 3.652 |
| 2025-12-31 | 6.168 | 0,61 | 3.762 |
| 2025-12-30 | 129.474 | 0,62 | 80.274 |
| 2025-12-29 | 33.798 | 0,65 | 21.969 |
| 2025-12-26 | 2.221 | 0,66 | 1.466 |